FoxO1 also contributes to hepatic inflammation, a key driver of NAFLD progression, by directly regulating the transcription of proinflammatory mediators like tumor necrosis factor‐alpha and interleukin‐1β [121]. Here, FOXO1 is linked to metabolic dysfunction-associated steatotic liver disease.